Medical Translation Services: Accuracy, Compliance, and What to Expect from a Specialist Agency

Key Takeaways

Medical translation services convert medical and pharmaceutical documents – patient records, clinical trial reports, regulatory dossiers, device labelling, informed consent forms and pharmaceutical product information – from one language into another with the accuracy and regulatory awareness that patient safety requires. Over 30% of translation errors in clinical settings lead to negative health outcomes, according to industry data. In regulated markets including the EU and US, inaccurate medical translation creates both patient risk and legal liability. This guide covers what medical translation involves, the regulatory standards that govern it, what qualifies a medical translator, and how to evaluate a specialist agency.

What Is Medical Translation?

Medical translation is the specialist translation of documents produced in, or for use in, the healthcare, pharmaceutical or medical device sectors. It requires a translator with both strong language skills and deep subject-matter knowledge – understanding of anatomy, pharmacology, clinical methodology, regulatory terminology and the specific document conventions of each document type.

The range of documents that require medical translation is broad:

• Patient records and medical reports – discharge summaries, diagnostic reports, operative notes, referral letters, pathology reports
• Clinical trial documentation – protocols, case report forms (CRFs), investigator brochures, adverse event reports, patient-reported outcomes (PROs)
• Regulatory submissions – Marketing Authorisation Applications (MAAs) for the EMA, New Drug Applications (NDAs) for the FDA, Medical Device Regulatory submissions under EU MDR
• Pharmaceutical product information – Summary of Product Characteristics (SmPC), Patient Information Leaflets (PILs), prescribing information
• Medical device documentation – Instructions for Use (IFU), labelling, service manuals, training materials (see our detailed guide to IFU translation for medical devices)
• Scientific and clinical literature – research papers, systematic reviews, conference abstracts, clinical guidelines
• Informed consent forms – patient consent documentation for clinical procedures and research participation
• Training and educational content – healthcare professional training materials, medical education content

Each document type carries its own terminology conventions, formatting requirements and quality standards. A clinical trial protocol translated by a general translator – however linguistically competent – creates regulatory and scientific risk.

The Regulatory Framework for Medical Translation

European Union: EU MDR 2017/745 and EMA Requirements

Under the EU Medical Device Regulation (MDR 2017/745), all labelling and instructions for use for medical devices placed on the EU market must be provided in the official language(s) of every EU member state where the device is sold. For a manufacturer with pan-EU distribution, this means translated content in up to 24 official EU languages.

The EMA (European Medicines Agency) requires that pharmaceutical product information – SmPCs, PILs and prescribing information – be provided in the language of each member state as part of a Marketing Authorisation. All translations must comply with the EMA’s QRD (Quality Review of Documents) template, which specifies formatting and terminology requirements.

United States: FDA Requirements

The FDA requires that labelling for all medical devices and pharmaceutical products sold in the US be accurate and understandable to the intended user population. Where a product’s user population includes non-English speakers – a common situation for medical devices used in clinical settings – Spanish and other language versions of labelling and IFU are required. FDA also requires that clinical trial documents submitted as part of a New Drug Application or Biologics License Application be accurately translated where they originated in another language.

Labelling and instructions for use are consistently among the top causes of medical device recalls. FDA data shows that labelling and instruction deficiencies account for over 30% of device recall actions – an indication of how directly translation quality affects compliance outcomes.

ISO Standards for Medical Translation

ISO 17100:2015 specifies requirements for translation service providers, including the qualification requirements for translators (relevant degrees or a combination of language qualification and five years of documented subject-matter experience). ISO 17100 is the minimum quality standard to expect from a medical translation agency.

For higher-risk content, agencies may also follow EN 15038 (the predecessor to ISO 17100) or apply ASTM F2575, the US standard for quality assurance in translation. Some pharmaceutical clients require translation to be conducted under ISO 9001-certified quality management systems.

What Qualifies a Medical Translator?

Medical translation is a restricted field. Not every professional translator is qualified to produce medical content – and assigning unqualified translators to medical documents is a recognised compliance risk.

A qualified medical translator typically has:

• A degree in translation, linguistics or a related field, or a degree in a medical or life sciences discipline with documented translation training
• Demonstrable subject-matter knowledge in the specific field (clinical research, pharmacology, medical device technology, etc.)
• Documented experience in medical translation – most specialist agencies require a minimum of three to five years of verifiable medical translation output
• Familiarity with the regulatory terminology and document conventions of the target market
• Knowledge of terminology resources specific to the field (MedDRA for adverse event coding, INN for pharmaceutical active substances, SNOMED CT for clinical terminology)

The distinction matters enormously. The difference between a professional translator and a bilingual colleague is always significant; in medical contexts, it is the difference between a compliant document and a liability.

Medical terminology also evolves. New drugs create new terminology, regulatory frameworks update their approved term lists, and clinical practice generates new vocabulary. A qualified medical translator keeps current with these changes through continuing professional development.

The Medical Translation Quality Process

Translation by a Subject-Specialist Linguist

The first translation pass is produced by a qualified translator with specific experience in the document type and clinical area. A translator who specialises in oncology clinical trial documentation is not automatically appropriate for medical device IFU for orthopaedic implants – both are medical, but the terminology, format conventions and regulatory requirements differ.

Independent Medical Editing

A second qualified translator reviews the first-pass translation for accuracy, terminology consistency, completeness and adherence to any client style guide or approved terminology list. In pharmaceutical translation, this step is sometimes performed by a bilingual subject-matter expert rather than a translator – a pharmacist or clinician who can verify that the medical content is correct in the target language, not just linguistically rendered.

Terminology Management

Professional medical translation agencies maintain client-specific Termbases and Translation Memories. For pharmaceutical clients, this means the same approved term is used for every occurrence of a drug name, clinical parameter or regulatory concept across all documents. Inconsistency in pharmaceutical terminology – using two different terms for the same adverse event, for example – creates regulatory risk in submissions and scientific risk in published research.

Back-Translation

For clinical trial documentation – particularly patient-reported outcome (PRO) instruments and informed consent forms – regulatory guidelines (ICH E6 and FDA guidance on PRO instruments) require back-translation: the translated document is independently translated back into the source language by a second translator who has not seen the original. Discrepancies between the back-translation and the original identify translation errors that would otherwise only become apparent after submission.

Regulatory Formatting

Medical documents for regulatory submission must conform to specified formatting requirements. EMA QRD templates, FDA eCTD structure and EU MDR labelling requirements all impose constraints on how the translated content is presented. An agency without regulatory experience may produce linguistically accurate translations that fail a formatting compliance check.

Medical Translation for Different Sectors

Pharmaceutical

Pharmaceutical medical translation covers the full product lifecycle: from pre-clinical and clinical trial documentation, through regulatory submissions to marketing authorisation, to post-market pharmacovigilance reporting and ongoing product information updates. Each phase carries its own regulatory requirements and document conventions.

Medical Devices

Medical device translation requirements are driven by EU MDR, US FDA 21 CFR Part 820, and equivalent regulations in other markets (MHLW in Japan, CDSCO in India, Health Canada in Canada). The most common documents requiring translation are IFU, labelling, technical documentation and quality management system records. For manufacturers distributing across the EU, the pan-EU translation programme for a CE-marked or MDR-approved device can involve up to 24 EU language versions of all patient-facing documentation.

Clinical Research

Contract Research Organisations (CROs) and pharmaceutical sponsors translate clinical trial documentation as part of multi-site, multi-country studies. Protocol translations must be accurate and consistent across all sites; informed consent forms must be understandable to patient populations with varying levels of health literacy; adverse event reports must use MedDRA-compliant terminology in all languages. Technical translation services built for complex documentation provide the process rigour that clinical research translation demands.

Patient Records and Medical Reports

Individual patients seeking treatment abroad, obtaining medical opinions in other countries, or submitting documentation for insurance claims require certified translations of medical records, diagnostic reports and specialist correspondence. These translations must be accurate and complete – omissions or errors directly affect clinical decision-making.

Healthcare Professional Training

Medical education content – clinical guidelines, training modules, simulation scenarios, case studies – requires translation that preserves the clinical accuracy and pedagogical intent of the original. A mistranslated clinical guideline taught to healthcare professionals in a target market creates patient risk at scale.

How to Evaluate a Medical Translation Agency

Translator Qualification and Vetting

Ask specifically how the agency qualifies medical translators. What educational background is required? What subject-matter experience? Are qualifications verified, and how? An agency that cannot answer these questions clearly does not have a defensible qualification process.

Quality Management Certification

ISO 17100 certification is the baseline. Ask for a copy of the certificate. For pharmaceutical clients, ask whether the agency operates under a quality management system auditable against ICH Q10 or similar pharmaceutical quality standards.

Therapeutic Area Experience

Medical translation is not a monolith. An agency with strong oncology experience may lack the cardiology or orthopaedic vocabulary for your project. Ask for examples of previous work in your specific therapeutic area or device category.

Regulatory Knowledge

The agency should demonstrate familiarity with the regulatory requirements in your target markets – EMA QRD templates, FDA eCTD structure, MDR labelling requirements, ICH guidelines for clinical documentation. This knowledge should be demonstrable, not just claimed.

Confidentiality and Data Security

Medical documents contain sensitive personal data (patient records, clinical trial subject information) and commercially sensitive information (regulatory submissions, proprietary clinical data). The agency should operate under data processing agreements compliant with GDPR and any applicable local data protection law, with documented security measures for handling client files.

Translation Memory and Terminology Assets

For ongoing programmes (pharmaceutical product information maintenance, device documentation updates, multi-year clinical trials), the agency should maintain and own your Translation Memories and Termbases, with the contractual right for you to retrieve them if you change agencies.

How Global LTS Supports Healthcare and Life Sciences Clients

Global Language Translation Services provides medical translation services to pharmaceutical companies, medical device manufacturers, CROs and healthcare organisations across the UK and internationally. Our medical translators are qualified subject specialists with experience across clinical research documentation, regulatory submissions, medical device IFU, patient information and healthcare professional training content.

We operate under ISO 17100 quality standards, maintain client-specific Termbases and Translation Memories and provide full project management across multi-language, multi-document programmes. Our 120+ language coverage includes all major EU languages, Japanese, Mandarin, Arabic and other regulated market languages.

Contact us to discuss your medical translation requirements and receive a tailored proposal.

Conclusion

Medical translation services require a higher standard of accuracy, subject-matter knowledge and regulatory compliance than any other translation discipline. The consequences of error – in patient safety, clinical data integrity and regulatory standing – are too significant to accept anything less than specialist provision. Selecting a qualified agency with documented quality processes, verifiable translator credentials and genuine regulatory knowledge protects your patients, your submissions and your organisation.